Coherus Oncology CHRS Earnings Call Transcripts

NASDAQ CHRS
$0.75 0.00 (-0.35%)
As of: Nov 6, 2026 · 9:38 AM EST
13 earnings calls on file for Coherus Oncology, from Q4 2019 to Q2 2026. Each transcript opens in a new tab.
Latest earnings call

Coherus Oncology Q2 2026 Earnings Call

Aug 5, 2026 5,860 words · 25 min read
  • Dennis LanfearChief Executive Officer
  • Rosh DiasChief Medical Officer
  • Theresa LavalleeChief Scientific and Development Officer
  • Sameer GoregaokerChief Commercial Officer
Prepared remarks and the full analyst Q&A, speaker by speaker.
Earnings calls

Coherus Oncology Earnings Call Transcripts

Calls13
LatestAug 5, 2026
SinceQ4 2019

Fiscal 2026

Fiscal 2022

Fiscal 2021

Fiscal 2020

Fiscal 2019

All 13 Coherus Oncology transcripts Register to get access to Coherus Oncology’s earnings call transcripts.